Pitman Jama 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
Pitman Jama
SVP, Regulatory & Quality
Transactions
- Sale
Common Stock
2023-12-13$15.37/sh−1,662$25,540→ 52,197 total - Award
Common Stock
2023-12-12+5,576→ 53,859 total
Footnotes (2)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On December 12, 2023, the Issuer's Compensation Committee confirmed that performance criteria one had been met, resulting in the vesting of 5,576 RSUs.
- [F2]This sale was to cover tax liabilities in the vesting of RSUs.